A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

This study is ongoing, but not recruiting participants.

Study NCT01263015 Information provided by ViiV Healthcare

First Received: December 16, 2010 Last Updated: May 10, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	March 2015
Estimated Primary Completion Date:	July 2012 (Final data collection date for primary outcome measure)